https://www.selleckchem.com/pr....oducts/hada-hydrochl
In our UFE population, uterine malignancy is rare (4/864, 0.46%), and MRI detected the majority, 3 (75%) of 4 before UFE. The observed prevalence of any malignancy was 0.35%, congruent with current Federal Drug Administration estimates. To determine the correlation between patient attributes and contrast enhancement in liver parenchyma and demonstrate the potential for patient-informed prediction and optimization of contrast enhancement in liver imaging. The study included 418 chest/abdomen/pelvis computed tomography scans, w
Curtir
Comentario
Compartilhar
